<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/44281153-8D26-4240-8D53-50B1781E71AE"><gtr:id>44281153-8D26-4240-8D53-50B1781E71AE</gtr:id><gtr:name>Marie Sklodowska-Curie Actions</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90765748-00A7-4D14-9C5F-F34DA45F3D55"><gtr:id>90765748-00A7-4D14-9C5F-F34DA45F3D55</gtr:id><gtr:name>Western University</gtr:name><gtr:address><gtr:line1>Western University Main Campus</gtr:line1><gtr:line2>#3, Street 528</gtr:line2><gtr:line3>Sangkat Boeung Kok I, Khan Tuol Kork</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4B6C2A2B-0BBF-4E20-B1B7-5226C468099C"><gtr:id>4B6C2A2B-0BBF-4E20-B1B7-5226C468099C</gtr:id><gtr:name>Rockefeller University</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8"><gtr:id>D97BD78E-DF6B-4FC6-8F27-BF3A5DA3EDD8</gtr:id><gtr:name>University of Ottawa</gtr:name><gtr:address><gtr:line1>550 Cumberland</gtr:line1><gtr:line4>Ottawa</gtr:line4><gtr:line5>Ontario K1N 6N5</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/44281153-8D26-4240-8D53-50B1781E71AE"><gtr:id>44281153-8D26-4240-8D53-50B1781E71AE</gtr:id><gtr:name>Marie Sklodowska-Curie Actions</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90765748-00A7-4D14-9C5F-F34DA45F3D55"><gtr:id>90765748-00A7-4D14-9C5F-F34DA45F3D55</gtr:id><gtr:name>Western University</gtr:name><gtr:address><gtr:line1>Western University Main Campus</gtr:line1><gtr:line2>#3, Street 528</gtr:line2><gtr:line3>Sangkat Boeung Kok I, Khan Tuol Kork</gtr:line3><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4B6C2A2B-0BBF-4E20-B1B7-5226C468099C"><gtr:id>4B6C2A2B-0BBF-4E20-B1B7-5226C468099C</gtr:id><gtr:name>Rockefeller University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/15760338-249A-4E2C-A464-38DCCDDA4227"><gtr:id>15760338-249A-4E2C-A464-38DCCDDA4227</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:surname>Gibbons</gtr:surname><gtr:orcidId>0000-0002-7680-9311</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12009%2F3"><gtr:id>518FC276-D073-4C3D-8CAC-B1AAF8175F37</gtr:id><gtr:title>Characterisation of ATRX, a chromatin remodelling protein</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12009/3</gtr:grantReference><gtr:abstractText>Despite the revolution in genetics in the last decade and in particular the sequencing of the human genome, the regulation of gene expression largely remains a mystery. Every cell of the body contains a full complement of genes but only expresses a small repertoire required for that tissues function, such as the oxygen carrying protein, haemoglobin, in red blood cells. A complex hierarchy of regulation is emerging involving tissue-specific signals, chemical modifications to the DNA molecule and the proteins about which DNA is wrapped, enzymes that package and unpackage DNA and different cellular compartments that either favour or repress gene expression. Human genetic diseases are now being identified in which the components of this complex apparatus are disrupted. In one such condition, ATR-X syndrome, the affected children have profound learning difficulties, a characteristic facial appearance, abnormalities of genital development and a form of anaemia. It arises because of mutations in a protein involved in the regulation of gene expression. The diverse problems probably reflect the many different genes whose expression is perturbed. The overall aim of this programme is to determine the role of such proteins in the regulation of gene expression and their involvement in human disease.</gtr:abstractText><gtr:technicalSummary>In the next phase of our research we wish to build on the success of the last five years to understand the role of ATRX in the gene expression and in particular how mutations in ATRX lead to down regulation of ? globin gene expression. The long term aim of this work is to see if this pathway is open to manipulation and whether it might be exploited therapeutically to modify the severity of ? thalassaemia by reducing the pathological accumulation of ? globin chains. 
It is apparent from our recent work that ATRX binds to tandem repeats throughout the genome. Many of these repeats are predicted to fold into non-B forms of DNA including G4 structures and we have shown that ATRX can bind G4 in vitro. When ATRX is mutated the expression of genes close to these ATRX targets is perturbed and the magnitude of the effect is related to the size of the repeat. It seems likely that ATRX modulates the effects of these repeats on gene expression. The current conundrum is how this might occur. Preliminary evidence suggests that ATRX plays a role in DNA replication and our working hypothesis is that these repeats and the structures they form inhibit the progress of the replication fork, a DNA damage response is triggered and as a consequence of this the expression of nearby genes is perturbed. A central focus of this programme will be to test this hypothesis and understand the mechanism underlying the abnormality in gene expression seen in individuals with ATR-X syndrome.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2447000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tumours of the nervous system: from biology to therapy</gtr:description><gtr:id>CDCD49A7-8FCD-4ABF-B478-C27E7520FFB4</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>5458a8a7a99551.41120969-1</gtr:outcomeId><gtr:partnerContribution>PML expertise</gtr:partnerContribution><gtr:piContribution>Provison of ATRX Knockout and Floxed mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Western University</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Characterisation of ATRX function in mouse brain</gtr:description><gtr:id>22B60070-342C-4883-8051-38E6D2B246CD</gtr:id><gtr:impact>19020049</gtr:impact><gtr:outcomeId>fu111i8cZdK-1</gtr:outcomeId><gtr:partnerContribution>Characterisation of ATRX function in mouse brain</gtr:partnerContribution><gtr:piContribution>Provided ATRX knockout and floxed mouse</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Marie Sklodowska-Curie Actions</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>DISCHROM</gtr:description><gtr:id>C1D1AA1A-97BF-4F25-B3EF-9D000BDFAB12</gtr:id><gtr:impact>Nil</gtr:impact><gtr:outcomeId>nAamhyo9U6f-1</gtr:outcomeId><gtr:partnerContribution>Nil</gtr:partnerContribution><gtr:piContribution>Graduate student in Initial Training Network</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ottawa</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:department>Ottawa Health Research Institute</gtr:department><gtr:description>Characterisation of ATRX function in mouse eye</gtr:description><gtr:id>8CBBE619-F826-4704-8F69-9124D1152145</gtr:id><gtr:impact>19088125</gtr:impact><gtr:outcomeId>UnVf2L4ABv6-1</gtr:outcomeId><gtr:partnerContribution>Characterisation of ATRX function in mouse eye</gtr:partnerContribution><gtr:piContribution>Provision of knockout and floxed ATRX mouse ATR-X syndrome data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Structural analysis of the ATRX ADD domain</gtr:description><gtr:id>ED0DA43B-4623-44B1-9A45-44B3667DB9A1</gtr:id><gtr:impact>17609377</gtr:impact><gtr:outcomeId>dGLNnp2K9HX-1</gtr:outcomeId><gtr:partnerContribution>1 paper 17609377</gtr:partnerContribution><gtr:piContribution>Determination of disease causing mutations. Design and synthesis of protein constructs.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Rockefeller University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Chromatin Biology and Epigenetics Rockefeller</gtr:department><gtr:description>Role of ATRX in H3.3 deposition</gtr:description><gtr:id>9E1CA05B-FA3A-4270-BAC7-1F1A33C1555D</gtr:id><gtr:impact>Paper in Cell: 20211137</gtr:impact><gtr:outcomeId>cccxXctiD21-1</gtr:outcomeId><gtr:partnerContribution>Paper in Cell: 20211137</gtr:partnerContribution><gtr:piContribution>Supplied ATRX knockout mouse ES cells, ATRX peptides and antibodies against ATRX</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oxford Science week</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>34003A27-9B0E-45E7-8568-4B1C9B85425C</gtr:id><gtr:impact>~100 individuals from the public attended the event

Great enthusiasm for the event, requests for work experience</gtr:impact><gtr:outcomeId>DsELuh5Xu69</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>Pre-2006,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Providing work experience placements for students (16yrs)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>666A064E-6196-4607-929B-C336499E6BB4</gtr:id><gtr:impact>Stimulates the interest of students in engaging in research

Great enthusiasm of participants</gtr:impact><gtr:outcomeId>PE7isTE4y5E</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>124000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Oxford Nuffield Medical Fellowship</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Nuffield Foundation</gtr:fundingOrg><gtr:id>2DC8DA44-BCD3-41C0-AFE5-B3A513D4CE80</gtr:id><gtr:outcomeId>5458ab3dab0e54.14466036</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>223000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Commonwealth Scholarship</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>The Commonwealth Fund</gtr:fundingOrg><gtr:id>66AC5DBB-5FB7-489D-BBEF-8AEDBF2A0B58</gtr:id><gtr:outcomeId>5458aabe197d37.80539450</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>213151</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>FP7 Marie Curie Network - ITN</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Marie Sklodowska-Curie Actions</gtr:fundingOrg><gtr:id>22F08DEC-0437-4848-97B1-F9A97E47092D</gtr:id><gtr:outcomeId>GeWSGG8tphR</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Daphne Jackson Trust</gtr:department><gtr:description>Daphne Jackson Fellowship</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>University of Surrey</gtr:fundingOrg><gtr:id>1193D9AB-D9F2-4808-B2B6-8110356876B0</gtr:id><gtr:outcomeId>5458aa4f310052.92872018</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>211702</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Research Training Fellowship</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>597DFE88-92EC-4F5E-9A3D-479283B74DDC</gtr:id><gtr:outcomeId>EvHw9VMVL8E</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Development of monoclonal antibodies against ATRX</gtr:description><gtr:grantRef>MC_UU_12009/3</gtr:grantRef><gtr:id>93F82D7B-1775-4DDD-A7AD-06F19748A39F</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56794efb5edf92.87372345</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>ATRX monoclonal antibodies</gtr:title><gtr:yearProtectionGranted>2015</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ATR-X diagnostics</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>39461F1A-8683-4A2A-8550-9313B0983456</gtr:id><gtr:impact>Characterisation of an important inherited cause of learning difficulties. Development of diagnostic test for this condition allowing accurate and timely diagnosis; carrier testing affording affected females the information regarding their risk of having an affected child; prenatal diagnosis leading to a decease in the incidence of ATR-X syndrome.</gtr:impact><gtr:outcomeId>SZ2D7wQLb9T</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Development of a functional test for ATR-X syndrome based on abnormal DNA methylation</gtr:description><gtr:id>CCEE04F2-DB5F-458B-AD04-621580C06A5A</gtr:id><gtr:impact>Identification of ATR-X syndrome in individuals negative using previous tests</gtr:impact><gtr:outcomeId>U1xrBipaLnJ</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Improved functional diagnostic test for ATR-X syndrome</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Conditional knockout for ATRX gene in mouse</gtr:description><gtr:id>3D926A2D-78FA-42B4-B78C-B93F1E19C76D</gtr:id><gtr:impact>Multiple publications on the function of ATRX</gtr:impact><gtr:outcomeId>P6t2js3bAtX</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Conditional knockout for ATRX gene in mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Cell lines from affected individuals</gtr:description><gtr:id>10B00C0D-072D-44F3-941C-36477E147D37</gtr:id><gtr:impact>Multiple publications</gtr:impact><gtr:outcomeId>KzFPz9G3c4t</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ATR-X syndrome cell line collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibody raise in collaboration with Kevin Gatter against both isoforms of the ATRX protein</gtr:description><gtr:id>7EF6A06E-1839-490B-BDB0-1AB5068FB562</gtr:id><gtr:impact>Many publications have resulted from the use of this reagent</gtr:impact><gtr:outcomeId>TZoFiRwQSq5</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ATRX monoclonal antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A9E2651C-4BD0-4F1F-B291-DB5A3EB34C1D</gtr:id><gtr:title>High-resolution analysis of cis-acting regulatory networks at the a-globin locus.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cca2e7f7d6bbe8f262c4bbbb765b9779"><gtr:id>cca2e7f7d6bbe8f262c4bbbb765b9779</gtr:id><gtr:otherNames>Hughes JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_15152_22_23650635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65FB7929-667C-49A0-964C-0809519C467A</gtr:id><gtr:title>ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/708f25fff3a52f9240891fd7c618e5d6"><gtr:id>708f25fff3a52f9240891fd7c618e5d6</gtr:id><gtr:otherNames>Law MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15152_22_21029860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FC2B82E-53D8-4988-9426-AD1D0197A05D</gtr:id><gtr:title>Gastrointestinal phenotype of ATR-X syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part A</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd11e59b608d617f2af46e4c9cc3a725"><gtr:id>cd11e59b608d617f2af46e4c9cc3a725</gtr:id><gtr:otherNames>Martucciello G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1552-4825</gtr:issn><gtr:outcomeId>pm_15152_12_16688741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86E89E24-99B8-4ECC-AC37-63EF4270D08A</gtr:id><gtr:title>The chromatin remodeller ATRX: a repeat offender in human disease.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce217e81a00dce6e5d21eeb097f2a12"><gtr:id>fce217e81a00dce6e5d21eeb097f2a12</gtr:id><gtr:otherNames>Clynes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>pm_15152_22_23916100</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5E8F3CF-705C-4C75-941A-49344CD3A292</gtr:id><gtr:title>JAK2V617F promotes replication fork stalling with disease-restricted impairment of the intra-S checkpoint response.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1dbccca2b43bf9b0bbe63360174cb7"><gtr:id>1d1dbccca2b43bf9b0bbe63360174cb7</gtr:id><gtr:otherNames>Chen E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5458a3fb310389.51187363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10E44BC6-40EE-4508-A1A5-83A565D0F4E6</gtr:id><gtr:title>Tissue-specific histone modification and transcription factor binding in alpha globin gene expression.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>pm_15152_12_17715390</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5921DFA1-BB11-46F7-A393-B193CB8EBA96</gtr:id><gtr:title>Maintaining memory of silencing at imprinted differentially methylated regions.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461341f86b0010ce65b9c4daceda43e8"><gtr:id>461341f86b0010ce65b9c4daceda43e8</gtr:id><gtr:otherNames>Voon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>585d530d49a5d6.86619336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F718D8E-A9E7-4698-878A-0708EE23561C</gtr:id><gtr:title>Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce217e81a00dce6e5d21eeb097f2a12"><gtr:id>fce217e81a00dce6e5d21eeb097f2a12</gtr:id><gtr:otherNames>Clynes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5675e7e071403</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36621CC8-40A9-4444-A826-A683DB1660D6</gtr:id><gtr:title>Generation of bivalent chromatin domains during cell fate decisions.</gtr:title><gtr:parentPublicationTitle>Epigenetics &amp; chromatin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1756-8935</gtr:issn><gtr:outcomeId>pm_15152_22_21645363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E69A715-2FCC-4AB8-96F1-B127E36AD1FF</gtr:id><gtr:title>The molecular basis of a-thalassemia: a model for understanding human molecular genetics.</gtr:title><gtr:parentPublicationTitle>Hematology/oncology clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0889-8588</gtr:issn><gtr:outcomeId>pm_15152_22_21075279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF153A3E-39F9-446B-9798-0080B04A5527</gtr:id><gtr:title>The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c28c456764709352f40d2dd6fba125f"><gtr:id>8c28c456764709352f40d2dd6fba125f</gtr:id><gtr:otherNames>Nguyen DT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>5a2fd339ce8a87.16336655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>00B7E9F0-7A22-4D7C-BC72-3A668074DCCB</gtr:id><gtr:title>Using genomics to study how chromatin influences gene expression.</gtr:title><gtr:parentPublicationTitle>Annual review of genomics and human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e9a17e3016005ab525dab981b1cf314"><gtr:id>1e9a17e3016005ab525dab981b1cf314</gtr:id><gtr:otherNames>Higgs DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1527-8204</gtr:issn><gtr:outcomeId>pm_15152_12_17506662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07F9DF14-1AD2-4903-ADA1-2AF3AD71BABD</gtr:id><gtr:title>Selective silencing of a-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Haematologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0390-6078</gtr:issn><gtr:outcomeId>58b05f1a9f8750.55306996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A9161DE-A5AE-42E2-BB17-DF6D00632339</gtr:id><gtr:title>a-Globin as a molecular target in the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>58b05f1ae88055.97058251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE96EE46-A2AB-412D-AB57-0B51D890D8CC</gtr:id><gtr:title>ATRX and the replication of structured DNA.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce217e81a00dce6e5d21eeb097f2a12"><gtr:id>fce217e81a00dce6e5d21eeb097f2a12</gtr:id><gtr:otherNames>Clynes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn><gtr:outcomeId>pm_15152_22_23453691</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BBF717D-7CEC-48A7-9A3D-30BD886BB203</gtr:id><gtr:title>Alpha thalassaemia-mental retardation, X linked.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/252af2121816d1321e9544916cd57745"><gtr:id>252af2121816d1321e9544916cd57745</gtr:id><gtr:otherNames>Gibbons R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>pm_15152_12_16722615</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6178AF7C-D622-4D7C-91C5-479D0496DF3B</gtr:id><gtr:title>XNP/ATRX at sites of nucleosome replacement.</gtr:title><gtr:parentPublicationTitle>Epigenomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62f919c1ce48564e23cc6ba86f4ad99"><gtr:id>b62f919c1ce48564e23cc6ba86f4ad99</gtr:id><gtr:otherNames>Garrick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1750-192X</gtr:issn><gtr:outcomeId>pm_15152_22_22229159</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBA2E1D6-FAAA-4B5F-B793-C50192021D56</gtr:id><gtr:title>Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3b77daf4d10114134a7837bd0d997445"><gtr:id>3b77daf4d10114134a7837bd0d997445</gtr:id><gtr:otherNames>Qiao Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15152_22_24130152</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>217AD927-B23D-42F9-BB31-BE3CC3EDF77B</gtr:id><gtr:title>Functional significance of mutations in the Snf2 domain of ATRX.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cd3ca91810ebfbda5aaf1fe5470d48b"><gtr:id>1cd3ca91810ebfbda5aaf1fe5470d48b</gtr:id><gtr:otherNames>Mitson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15152_22_21505078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>635201AB-C859-48EA-8999-1E86F166BE2F</gtr:id><gtr:title>A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/176b59cd6681e624045d11349b7b0e8d"><gtr:id>176b59cd6681e624045d11349b7b0e8d</gtr:id><gtr:otherNames>De Gobbi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>pm_15152_12_16728641</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>036BB59B-9A44-4DA3-98FA-3087E27A59FE</gtr:id><gtr:title>Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b478d5235b8c6069d0ed8d91c32c87f2"><gtr:id>b478d5235b8c6069d0ed8d91c32c87f2</gtr:id><gtr:otherNames>Argentaro A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_15152_12_17609377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9CC5ED0-9435-427B-A419-5FB2D071E187</gtr:id><gtr:title>Combinatorial readout of histone H3 modifications specifies localization of ATRX to heterochromatin.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca3bd30d9fd5f85dd44493aa3a988cd0"><gtr:id>ca3bd30d9fd5f85dd44493aa3a988cd0</gtr:id><gtr:otherNames>Eustermann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>pm_15152_22_21666677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BBC87446-F3A9-4F64-B541-9B057061E5C5</gtr:id><gtr:title>The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4acc0ed8b25499885c3b4ff05c5c521b"><gtr:id>4acc0ed8b25499885c3b4ff05c5c521b</gtr:id><gtr:otherNames>Schwab RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56794125a7df91.12729749</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A294808-9A99-422E-9F99-A8CE2CF2A431</gtr:id><gtr:title>ATRX dysfunction induces replication defects in primary mouse cells.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fce217e81a00dce6e5d21eeb097f2a12"><gtr:id>fce217e81a00dce6e5d21eeb097f2a12</gtr:id><gtr:otherNames>Clynes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5458a5d6295d67.32848616</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4109D20-89C6-415B-92BD-1CB097A679D3</gtr:id><gtr:title>Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/793a2f179bace44a03e5feed6baed4c6"><gtr:id>793a2f179bace44a03e5feed6baed4c6</gtr:id><gtr:otherNames>Medina CF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15152_12_19088125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E2166DC-6498-4CB6-B102-43AB2B8C268F</gtr:id><gtr:title>The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS).</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7559b6b5e8b26bd2b1530ac9fbe4c955"><gtr:id>7559b6b5e8b26bd2b1530ac9fbe4c955</gtr:id><gtr:otherNames>Haas PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_15152_12_19055664</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>032D2ACD-1ED8-4173-810A-3F9AC3491AA0</gtr:id><gtr:title>ATRX: taming tandem repeats.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f526570d3844b0ac238950732a090d"><gtr:id>b1f526570d3844b0ac238950732a090d</gtr:id><gtr:otherNames>Gibbons RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>pm_15152_22_21099363</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72DF5E75-071F-4D27-8D62-2D29BD0A344E</gtr:id><gtr:title>An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcf85181d460d7697454708928c59a0c"><gtr:id>fcf85181d460d7697454708928c59a0c</gtr:id><gtr:otherNames>Lynch MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_15152_22_22056776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5639376-C04C-4737-B7F7-3126B8C8764B</gtr:id><gtr:title>Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b62f919c1ce48564e23cc6ba86f4ad99"><gtr:id>b62f919c1ce48564e23cc6ba86f4ad99</gtr:id><gtr:otherNames>Garrick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_15152_12_16628246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE36FAB5-798C-4F28-862B-C85E5926F863</gtr:id><gtr:title>Mutations in the chromatin-associated protein ATRX.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f526570d3844b0ac238950732a090d"><gtr:id>b1f526570d3844b0ac238950732a090d</gtr:id><gtr:otherNames>Gibbons RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15152_12_18409179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C56B8735-CB9A-480C-AC3B-6260C4647893</gtr:id><gtr:title>ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/461341f86b0010ce65b9c4daceda43e8"><gtr:id>461341f86b0010ce65b9c4daceda43e8</gtr:id><gtr:otherNames>Voon HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>567940b70ff9a1.85019233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76443AE0-73DD-4C29-A995-9CE822ED34D1</gtr:id><gtr:title>Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/99ac403c7fa258a68b80b7fdbbec57e2"><gtr:id>99ac403c7fa258a68b80b7fdbbec57e2</gtr:id><gtr:otherNames>Giardine B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_15152_22_21423179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>697CECB2-0BB2-4246-B8AC-9247F6231A73</gtr:id><gtr:title>Analysis of sequence variation underlying tissue-specific transcription factor binding and gene expression.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e65cb340e28a6716f46340257fd22fec"><gtr:id>e65cb340e28a6716f46340257fd22fec</gtr:id><gtr:otherNames>Lower KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15152_22_23616472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BD88702-750A-4C8A-A004-2CBFCF8AD3A2</gtr:id><gtr:title>Distinct factors control histone variant H3.3 localization at specific genomic regions.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b681063147f8df6b34dfde27a60c4f8"><gtr:id>2b681063147f8df6b34dfde27a60c4f8</gtr:id><gtr:otherNames>Goldberg AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>pm_15152_22_20211137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAE2F736-5DE6-4051-B6D9-A42D9078A526</gtr:id><gtr:title>X-linked alpha thalassaemia/mental retardation syndrome: a case with gonadal dysgenesis, caused by a novel mutation in ATRX gene.</gtr:title><gtr:parentPublicationTitle>Clinical dysmorphology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f067d80044230e4f83ac7410b3b159d1"><gtr:id>f067d80044230e4f83ac7410b3b159d1</gtr:id><gtr:otherNames>Jezela-Stanek A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0962-8827</gtr:issn><gtr:outcomeId>pm_15152_12_19444090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BB5E2075-40A3-4D97-A9C3-35BA2757875C</gtr:id><gtr:title>Understanding a-globin gene regulation and implications for the treatment of ?-thalassemia.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3297a1f6c21d3ca7582bf78aca9e5800"><gtr:id>3297a1f6c21d3ca7582bf78aca9e5800</gtr:id><gtr:otherNames>Mettananda S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>58b05f1ac7ad60.56281443</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FA066CD-CDDC-491B-AE4F-3E0D2F41E44F</gtr:id><gtr:title>Intragenic enhancers act as alternative promoters.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac9f815f8954a372c5b5386ab75d02e0"><gtr:id>ac9f815f8954a372c5b5386ab75d02e0</gtr:id><gtr:otherNames>Kowalczyk MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_15152_22_22264824</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D9AA7C80-F0F1-4E8A-8949-0A3317E7A03C</gtr:id><gtr:title>Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48237da23a0f64a5f2ba71ec22b9273a"><gtr:id>48237da23a0f64a5f2ba71ec22b9273a</gtr:id><gtr:otherNames>Muers MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15152_12_17503331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD853939-38DB-4A42-9CAE-70E725DAF318</gtr:id><gtr:title>Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.</gtr:title><gtr:parentPublicationTitle>British journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a34c1e449c183bb1e5e02ab1f8e0b9a4"><gtr:id>a34c1e449c183bb1e5e02ab1f8e0b9a4</gtr:id><gtr:otherNames>Steensma DP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0007-1048</gtr:issn><gtr:outcomeId>pm_15152_12_17910635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6CF6290-00F4-4B53-8EB5-CF3E153C739B</gtr:id><gtr:title>a-Thalassemia, mental retardation, and myelodysplastic syndrome.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b1f526570d3844b0ac238950732a090d"><gtr:id>b1f526570d3844b0ac238950732a090d</gtr:id><gtr:otherNames>Gibbons RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2157-1422</gtr:issn><gtr:outcomeId>pm_15152_22_23028133</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A77FBD6-A151-42AA-8EA0-CC31A1691423</gtr:id><gtr:title>A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome.</gtr:title><gtr:parentPublicationTitle>European journal of haematology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecf0e0a08aaad835b94aa5a80436ae49"><gtr:id>ecf0e0a08aaad835b94aa5a80436ae49</gtr:id><gtr:otherNames>Costa DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0902-4441</gtr:issn><gtr:outcomeId>pm_15152_12_16480427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>350FAE85-8208-4910-86BB-760645774D7F</gtr:id><gtr:title>Nprl3 is required for normal development of the cardiovascular system.</gtr:title><gtr:parentPublicationTitle>Mammalian genome : official journal of the International Mammalian Genome Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac9f815f8954a372c5b5386ab75d02e0"><gtr:id>ac9f815f8954a372c5b5386ab75d02e0</gtr:id><gtr:otherNames>Kowalczyk MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0938-8990</gtr:issn><gtr:outcomeId>pm_15152_22_22538705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41CA9E91-CEEF-4240-A698-B150470046C7</gtr:id><gtr:title>Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0487957c0eb08db37f1c97b89840d2c0"><gtr:id>0487957c0eb08db37f1c97b89840d2c0</gtr:id><gtr:otherNames>Seah C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_15152_12_19020049</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12009/3</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>